Guidelines for primary radiotherapy of patients with prostate cancer

被引:118
作者
Boehmer, Dirk [1 ]
Maingon, Philippe
Poortmans, Philip
Baron, Marie-Helene
Miralbell, Raymond
Remouchamps, Vincent
Scrase, Christopher
Bossi, Alberto
Bolla, Michel
机构
[1] Reg & Univ Med Berlin, Charite, Klin F Strahlentherapie, Berlin, Germany
[2] Ctr Georges Francois Leclerc, Unite Radiotherapie, Dijon, France
[3] Dr B Verbeeten Inst, Tilburg, Netherlands
[4] Univ Hosp Jean Minjoz, Besancon, France
[5] Serv Radiotherapie CH, Besancon, France
[6] Hop Univ Geneva, Div Radiooncol, Geneva, Switzerland
[7] Hop Univ, Div Radiooncol, Geneva, Switzerland
[8] Clin & Maternite Ste Elisabeth, Serv Oncol Radiotherapie & Med Nucl, Namur, Belgium
[9] Ipswich Hosp NHS Trust, Ipswich, Suffolk, England
[10] Univ Hosp Gasthuisberg, Dept Radiotherapy, Louvain, Belgium
关键词
prostate cancer; target definition; organ at risk definition; imaging; image guided radiotherapy; IMRT; guidelines;
D O I
10.1016/j.radonc.2006.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purposes: The, appropriate application of 3-D conformal radiotherapy, intensity modulated radiotherapy or image guided radiotherapy for patients undergoing radiotherapy for prostate cancer requires a standardisation of target delineation as well as clinical quality assurance procedures. Patients and methods: Pathological and imaging studies provide valuable information on tumour extension. In addition, clinical investigations on patient positioning and immobilisation as well as treatment verification data offer an abundance of information. Results: Target volume definitions for different risk groups of prostate cancer patients based on pathological and imaging studies are provided. Available imaging modalities, patient positioning and treatment preparation studies as well as verification procedures are collected from literature studies. These studies are summarised and recommendations are given where appropriate. Conclusions: On behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Radiation Oncology Group this article presents a common set of recommendations for external beam radiotherapy of patients with prostate cancer. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:259 / 269
页数:11
相关论文
共 92 条
  • [1] Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
    Ataman, F
    Zurlo, A
    Artignan, X
    van Tienhoven, G
    Blank, LE
    Warde, P
    Dubois, JB
    Jeanneret, W
    Keuppens, F
    Bernier, J
    Kuten, A
    Collette, L
    Pierart, M
    Bolla, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (11) : 1674 - 1681
  • [2] Comparability of CT-based and TRUS-based prostate volumes
    Badiozamani, KR
    Wallner, K
    Cavanagh, W
    Blasko, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02): : 375 - 378
  • [3] Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities
    Baum, C
    Alber, M
    Birkner, M
    Nüsslin, F
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 78 (01) : 27 - 35
  • [4] Dosimetric consequences of the application of off-line setup error correction protocols and a hull-volume definition strategy for intensity modulated radiotherapy of prostate cancer
    Baum, C
    Birkner, M
    Alber, M
    Paulsen, F
    Nüsslin, F
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 76 (01) : 35 - 42
  • [5] A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer
    Bayley, AJ
    Catton, CN
    Haycocks, T
    Kelly, V
    Alasti, H
    Bristow, R
    Catton, P
    Crook, J
    Gospodarowicz, MK
    McLean, M
    Milosevic, M
    Warde, P
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 70 (01) : 37 - 44
  • [6] Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer
    Beard, CJ
    Chen, MH
    Cote, K
    Loffredo, M
    Renshaw, AA
    Hurwitz, M
    D'Amico, AV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01): : 19 - 24
  • [7] Performing daily prostate targeting with a standard V-EPID and an automated radio-opaque marker detection algorithm
    Beaulieu, L
    Girouard, LM
    Aubin, S
    Aubry, JF
    Brouard, L
    Roy-Lacroix, L
    Dumont, J
    Tremblay, D
    Laverdière, J
    Vigneault, E
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 73 (01) : 61 - 64
  • [8] LATE RECTAL BLEEDING FOLLOWING COMBINED X-RAY AND PROTON HIGH-DOSE IRRADIATION FOR PATIENTS WITH STAGES T3-T4 PROSTATE CARCINOMA
    BENK, VA
    ADAMS, JA
    SHIPLEY, WU
    URIE, MM
    MCMANUS, PL
    EFIRD, JT
    WILLETT, CG
    GOITEIN, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (03): : 551 - 557
  • [9] Boehmer D, 2006, STRAHLENTHER ONKOL, V182, P277, DOI 10.1007/s00066-006-1462-7
  • [10] Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer
    Boehmer, D
    Bohsung, J
    Eichwurzel, I
    Moys, A
    Budach, V
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 (03) : 319 - 325